Malta - English - Medicines Authority

glaxo smithkline ireland limited 12, riverwalk, citywest business campus, dublin 24, ireland - hepatitis b, surface antigen, recombinant - suspension for injection - hepatitis b surface antigen, recombinant 20 µg/l - vaccines

Malta - English - Medicines Authority

glaxo smithkline ireland limited 12, riverwalk, citywest business campus, dublin 24, ireland - hepatitis b, surface antigen, recombinant - suspension for injection - hepatitis b surface antigen, recombinant 20 µg/l - vaccines

United States - English - NLM (National Library of Medicine)

deseret biologicals, inc. - human adenovirus e serotype 4 strain cl-68578 antigen (unii: fkd3duk39i) (human adenovirus e serotype 4 strain cl-68578 - unii:fkd3duk39i), human herpesvirus 5 (unii: 7coi029e6k) (human herpesvirus 5 - unii:7coi029e6k), human herpesvirus 1 (unii: 22g38p19rl) (human herpesvirus 1 - unii:22g38p19rl), human herpesvirus 2 (unii: 74j6dnh49u) (human herpesvirus 2 - unii:74j6dnh49u), human herpesvirus 4 (unii: 2a26yw7pnx) (human herpesvirus 4 - unii:2a26yw7pnx), hepatitis b virus (unii: 77h9em77p7) (hepatitis b virus - unii:77h9em77p7), human herpesvirus 6 (unii: 4ix4vp35cr) (human herpesvirus 6 - unii:4ix4vp35cr), influenza a virus a/victoria/2570/2019 ivr-215 (h1n1) antigen (uv, formaldehyde inactivated) (unii: 34c49nv47p) (influenza a virus a/victoria/2570/2019 ivr-215 (h1n1) hemagglutinin antigen (uv, formaldehyde inactivated) - unii:ngl844y7x6), influenza a virus a/darwin/9/2021 ivr-228 (h3n2) antigen (uv, formaldehyde inactivated) (unii: p483j7gx6d) (influenza a virus a/darwin/9/2021 ivr-228 (h3n2) hemagglutinin antigen (uv, formaldehyde inactivated) - unii:grn94tp8yv), influenza b virus b/austria/1359417/2021 bvr-26 antigen (uv, formaldehyde inactivated) (unii: tbv2ppg6ef) (influenza b virus b/austria/1359417/2021 bvr-26 hemagglutinin antigen (uv, formaldehyde inactivated) - unii:28eah8253x), influenza b virus b/phuket/3073/2013 antigen (uv, formaldehyde inactivated) (unii: h2198f8zna) (influenza b virus b/phuket/3073/2013 hemagglutinin antigen (uv, formaldehyde inactivated) - unii:3vsf1bf3sr) - adenoviren nosode – cold symptoms, cytomegalovirus nosode - headache, dna - fatigue, muscle aches and pain, epstein-barr virus nosode - fever, hepatitis b nosode – muscle aches and pains, herpes simplex 1 & 2 nosode - rash, human herpesvirus 6a - herpes, human herpesvirus 6b - fatigue, influenzinum – flu symptoms. • for the temporary relief of symptoms including: • cold symptoms  • fever  fatigue  • muscle aches and pains   • headache  • rash  • herpes  • flu symptoms these statements are based upon homeopathic principles. they have not been reviewed by the food and drug administration.

New Zealand - English - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - hepatitis b surface antigen, recombinant 20 µg/ml; hepatitis b surface antigen, recombinant 20 µg/ml - suspension for injection - 10 mcg/0.5ml - active: hepatitis b surface antigen, recombinant 20 µg/ml excipient: aluminium hydroxide dibasic sodium phosphate dihydrate monobasic sodium phosphate dihydrate phenoxyethanol sodium chloride thiomersal water for injection active: hepatitis b surface antigen, recombinant 20 µg/ml excipient: aluminium hydroxide dibasic sodium phosphate dihydrate monobasic sodium phosphate dihydrate sodium chloride water for injection - engerix-b is indicated for active immunization against hepatitis b virus infection.

New Zealand - English - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - hepatitis b surface antigen, recombinant 20 µg/ml; hepatitis b surface antigen, recombinant 20 µg/ml - suspension for injection - 20 mcg/ml - active: hepatitis b surface antigen, recombinant 20 µg/ml excipient: aluminium hydroxide dibasic sodium phosphate dihydrate monobasic sodium phosphate dihydrate phenoxyethanol sodium chloride thiomersal water for injection active: hepatitis b surface antigen, recombinant 20 µg/ml excipient: aluminium hydroxide dibasic sodium phosphate dihydrate monobasic sodium phosphate dihydrate sodium chloride water for injection - engerix-b is indicated for active immunization against hepatitis b virus infection.

New Zealand - English - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - hepatitis a vaccine 1440 eu/ml (virus antigen (hm175 strain)); vi capsular polysaccharide of s. typhi ty2 25 µg/ml;   - suspension for injection - active: hepatitis a vaccine 1440 eu/ml (virus antigen (hm175 strain)) vi capsular polysaccharide of s. typhi ty2 25 µg/ml   excipient: aluminium hydroxide amino acids formaldehyde neomycin sulfate polysorbate 20 sodium chloride trometamol water for injection - hepatyrix is indicated for active immunisation of adults and adolescents older than 15 years of age at risk of both hepatitis a virus infection and typhoid fever. immunisation with hepatyrix is particularly recommended in subjects who are, or will be, at increased risk of infection such as travellers from countries of low endemicity to areas where the prevalence of hepatitis a and typhoid fever is high.

European Union - English - EMA (European Medicines Agency)

sanofi pasteur - hepatitis b surface antigen, diphtheria toxoid, tetanus toxoid, bordetella pertussis antigens pertussis toxoid filamentous haemagglutinin, poliovirus (inactivated) type 1 (mahoney) type 2 (mef-1) type 3 (saukett), haemophilus influenzae type b polysaccharide (polyribosylribitol phosphate) conjugated to tetanus protein - hepatitis b; tetanus; immunization; meningitis, haemophilus; whooping cough; poliomyelitis; diphtheria - vaccines, bacterial and viral vaccines, combined - hexacima (dtap-ipv-hb-hib) is indicated for primary and booster vaccination of infants and toddlers from six weeks of age against diphtheria, tetanus, pertussis, hepatitis b, poliomyelitis and invasive diseases caused by haemophilus influenzae type b (hib).the use of this vaccine should be in accordance with official recommendations.

European Union - English - EMA (European Medicines Agency)

sanofi pasteur msd, snc - polyribosylribitol phosphate from haemophilus influenzae type b as prp-ompc, outer membrane protein complex of neisseria meningitidis (outer membrane protein complex of the b11 strain of neisseria meningitidis subgroup b), adsorbed hepatitis b surface antigen produced in recombinant yeast cells (saccharomyces cerevisiae) - hepatitis b; meningitis, haemophilus; immunization - vaccines - procomvax is indicated for vaccination against invasive disease caused by haemophilus influenzae type b and against infection caused by all known subtypes of hepatitis b virus in infants 6 weeks to 15 months of age.,

Kenya - English - Pharmacy and Poisons Board

serum institute of india ltd. 212/2 hadapsar pune 411028 india - hepatitis b vaccine (rdna) (adult) - suspension for injection - each dose of 1 ml contains purified hepatitis b… - viral vaccines: hepatitisvaccines

Kenya - English - Pharmacy and Poisons Board

serum institute of india ltd. 212/2 hadapsar pune 411028 india - hepatitis b vaccine (rdna) (paediatric) - suspension for injection - each dose of 0.5 ml contains purified hepatitis… - viral vaccines: hepatitisvaccines